Delivery Order SPE2DB24D3015-SPE2DB25FFYET

Award Date 2/24/25
Potential Completion Date 2/25/25
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,546.96 firm fixed-price delivery order is for the supply of Lyrica 50 mg capsules. The contract has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,140.51 fixed-price delivery order is for Lyrica 50 mg capsules and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,202.84 firm fixed-price delivery order is for the supply of Lyrica 300 mg capsules and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,738.40 Firm Fixed Price delivery order contract is for the supply of Lyrica 25 mg capsules. The award has an ultimate completion date of February 12, 2025 and was made on February 11, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,386.46, is for the delivery of Lyrica 200 mg capsules. It is a firm-fixed-price delivery order contract with a completion date of December 13, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,615.05, is a delivery order to supply Lyrica 300 mg capsules to support military healthcare programs. The contract has a firm fixed price pricing type and an ultimate completion date of November 13, 2024. The award is not designated with a set-aside requirement, indicating open competition....
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Lyrica 150 mg capsules. The contract, valued at $2,689.50, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of October 7, 2024. Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), has a significant Indefinite Delivery...
This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,382.13, is a delivery order for Lyrica 75 mg capsules. The contract has an ultimate completion date of November 30, 2023 and is a firm fixed-price agreement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lyrica 150 mg capsules. The $5,241.11 firm-fixed-price contract has an ultimate completion date of August 28, 2024 and was awarded on August 27, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide 4,562,300 units of Lyrica 50 mg capsules. The $3,458.71 firm fixed-price delivery order has a completion date of September 26, 2023 and is not associated with any set-aside requirements. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFYET
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,734.03, is for the delivery of Lyrica 300 mg capsules. This contract does not have a set-aside designation, indicating open competition.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 6/1/25, 2:42 AM